Latest / Lung Cancer Considered
Lung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ
The FDA has approved subcutaneous amivantamab. Join host Dr. Narjust Florez and guests, Dr. Natasha Leighl and Dr. Federico Cappuzzo, as they explore the science and convenience factor, as well as what this shift means for patients, clinicians, and oncology practice.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.